File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A questionnaire study on disparity of cervical cancer prevention programs in Asia‐Oceania

TitleA questionnaire study on disparity of cervical cancer prevention programs in Asia‐Oceania
Authors
Keywordscancer of the cervix
HPV infection and CIN
Issue Date16-Jul-2023
PublisherWiley
Citation
Journal of Obstetrics and Gynaecology Research, 2023, v. 49, n. 4, p. 1230-1243 How to Cite?
Abstract

Background: Despite the introduction of cervical cancer screening and human papillomavirus (HPV) vaccines, the utilization pattern was not standardized. The aim of this study was to elicit the current prevention care in Asia-Oceania.Methods: An online questionnaire was circulated to different countries/cities in Asia-Oceania. The primary objective was to evaluate the coverage of HPV vaccination and cervical screening programs. The secondary objectives were to study the structures of these programs. Five case scenarios were set to understand how the respondents manage the abnormal screening results.Results: Fourteen respondents from 10 countries/cities had participated. Cervical cancer ranked the first in Myanmar and Nepal. About 10%-15% did not have national vaccination or screening program. The estimated coverage rate for vaccination and screening varied from less than 1% to 70%, which the coverage ran in parallel with the incidence and mortality rates of cervical cancer. All regions approved HPV vaccines, although only four provided free or subsidized programs for nonavalent vaccine. Cervical cytology remained the most common screening tool, and 20%-30% relied heavily on visual inspection using acetic acid. The screening age groups varied in different regions. From the case scenarios, it was noted that some respondents tended to offer more frequent screening tests or colposcopy than recommended by international guidelines.Conclusion: This study revealed discrepancy in the practice of cervical cancer prevention in Asia-Oceania especially access to HPV vaccines. There is an urgent need for a global collaboration to eliminate cervical cancer by public education, reforming services, and medical training.


Persistent Identifierhttp://hdl.handle.net/10722/337881
ISSN
2023 Impact Factor: 1.6
2023 SCImago Journal Rankings: 0.576
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorTse, Ka Yu-
dc.contributor.authorUshijima, Kimio-
dc.contributor.authorTan, Ai Ling-
dc.contributor.authorIntasorn, Perapong-
dc.contributor.authorPariyar, Jitendra-
dc.contributor.authorChang, Chih‐Long-
dc.contributor.authorDomingo, Efren J-
dc.contributor.authorKonar, Hiralal-
dc.contributor.authorKumarasamy, Suresh-
dc.contributor.authorTjokroprawiro, Brahmana Askandar-
dc.contributor.authorWilailak, Sarikapan-
dc.contributor.authorThe Oncology Committee, Asia and Oceania Federation of Obstetrics and Gynecology-
dc.date.accessioned2024-03-11T10:24:36Z-
dc.date.available2024-03-11T10:24:36Z-
dc.date.issued2023-07-16-
dc.identifier.citationJournal of Obstetrics and Gynaecology Research, 2023, v. 49, n. 4, p. 1230-1243-
dc.identifier.issn1341-8076-
dc.identifier.urihttp://hdl.handle.net/10722/337881-
dc.description.abstract<p>Background: Despite the introduction of cervical cancer screening and human papillomavirus (HPV) vaccines, the utilization pattern was not standardized. The aim of this study was to elicit the current prevention care in Asia-Oceania.Methods: An online questionnaire was circulated to different countries/cities in Asia-Oceania. The primary objective was to evaluate the coverage of HPV vaccination and cervical screening programs. The secondary objectives were to study the structures of these programs. Five case scenarios were set to understand how the respondents manage the abnormal screening results.Results: Fourteen respondents from 10 countries/cities had participated. Cervical cancer ranked the first in Myanmar and Nepal. About 10%-15% did not have national vaccination or screening program. The estimated coverage rate for vaccination and screening varied from less than 1% to 70%, which the coverage ran in parallel with the incidence and mortality rates of cervical cancer. All regions approved HPV vaccines, although only four provided free or subsidized programs for nonavalent vaccine. Cervical cytology remained the most common screening tool, and 20%-30% relied heavily on visual inspection using acetic acid. The screening age groups varied in different regions. From the case scenarios, it was noted that some respondents tended to offer more frequent screening tests or colposcopy than recommended by international guidelines.Conclusion: This study revealed discrepancy in the practice of cervical cancer prevention in Asia-Oceania especially access to HPV vaccines. There is an urgent need for a global collaboration to eliminate cervical cancer by public education, reforming services, and medical training.</p>-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofJournal of Obstetrics and Gynaecology Research-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectcancer of the cervix-
dc.subjectHPV infection and CIN-
dc.titleA questionnaire study on disparity of cervical cancer prevention programs in Asia‐Oceania-
dc.typeArticle-
dc.identifier.doi10.1111/jog.15566-
dc.identifier.scopuseid_2-s2.0-85147447375-
dc.identifier.volume49-
dc.identifier.issue4-
dc.identifier.spage1230-
dc.identifier.epage1243-
dc.identifier.eissn1447-0756-
dc.identifier.isiWOS:000962254600021-
dc.identifier.issnl1341-8076-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats